Targeted Treatment of B-Cell Malignancies: Practical Strategies for BTK Inhibitors

Expert faculty discuss pharmacist considerations with BTK inhibitors for patients with CLL and MCL in a downloadable slideset, commentary, and on-demand webcast from a live webinar.

Share

Program Content

Activities

  • BTKis for CLL and MCL
    Practical Strategies for BTK Inhibitors in B-Cell Malignancies
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 16, 2022

    Expires: December 15, 2023

  • Targeted Treatment of B-Cell Malignancies: Practical Strategies for BTK Inhibitors
    Targeted Treatment of B-Cell Malignancies: Practical Strategies for BTK Inhibitors
    Credits Only
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 20, 2022

    Expires: February 20, 2023

  • Questions on BTK Inhibitors

    Pharmacists Discuss Key HCP Questions on BTK Inhibitors

    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 23, 2022

    Expires: December 22, 2023

  • BTKis for CLL and MCL
    Targeted Treatment of B-Cell Malignancies: Practical Strategies for BTK Inhibitors
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 01, 2023

    Expires: January 31, 2024

Faculty

cover img faculity

Karen M. Fancher, PharmD, BCOP

Associate Professor of Pharmacy Practice
Duquesne University School of Pharmacy
Clinical Pharmacy Specialist – Oncology
University of Pittsburgh Medical Center Passavant
Pittsburgh, Pennsylvania

cover img faculity

Anthony J. Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
University of Michigan
Ann Arbor, Michigan

Provided by

ProCE Banner
ProCE Banner

Supporters

Supported by an educational grant from

Pharmacyclics LLC, an AbbVie Company

Partners

National Association of Specialty Pharmacy

ProCE Banner